The Independent Voice of
European Private Equity

Advanced Search

Limerston Capital exits Arch Sciences

Samantha Birchall 20 July 2021

  • Limerston Capital has exited Arch Sciences Group following its sale to Element Materials Technology group.

Related Articles

Profile: Fondo Italiano d’Investimento celebrates raise of €1.2bn despite headwinds

08/05/24

Naxicap Partners acquires majority stake in spare parts distributor ITAL Express

08/05/24

Patrimonium and Wille Finance invest in EM

08/05/24

Montagu-backed HTL Biotechnology carves out Modern Meadow biomedical division

08/05/24

Squire Patton Boggs hires leveraged finance partner

08/05/24

Livonia Partners invests in Baltic tech firm Telema

08/05/24